Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


2nd Annual World Orphan Drug Congress 2012

17 Oct 2012 - 18 Oct 2012 - Barcelona, Spain



Bookmark and Share


In order to discuss major concerns, the newest solutions and challenges connected with prevention, diagnosis and treatment of rare diseases, Fleming Europe has organized its 2nd Annual Orphan Drug Congress 2012. On 17 – 18 October 2012 the top-level pharmaceutical experts in orphan drug development, regulatory affairs & pricing will gather in Barcelona to discuss this year's critical issues.

Focused interactive discussions integrated between individual presentation blocks will provide enough space and a unique opportunity to exchange ideas with industry peers and get the answers from our speakers.

The attendees will have the opportunity to:

  • Understand the infrastructure in order to gain approval in emerging markets 
  • Gain critical insights behind the successful development, authorization and  reimbursement of rare disease drugs 
  • Find out how to regulate the use of social media for orphan drugs & rare diseases 
  • Explore the importance of communication Between Pharma, Patient & HTA Bodies 
  • Meet the top executives and experts from leading pharmaceutical companies as well as  from medium and small pharma companies with the focus on rare and neglected    diseases

For further details please request the event brochure http://pharma.flemingeurope.com/orphan-drug-congress/request-agenda




Further information
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!